| Autor: |
Smirnikhina SA; a Laboratory of Mutagenesis , FSBI 'Research Centre for Medical Genetics' , Moscow , Russian Federation., Chelysheva EY; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Lavrov AV; a Laboratory of Mutagenesis , FSBI 'Research Centre for Medical Genetics' , Moscow , Russian Federation.; c Department of Molecular and Cellular Genetics , The Russian National Research Medical University Named after N.I. Pirogov , Moscow , Russian Federation., Kochergin-Nikitsky KS; a Laboratory of Mutagenesis , FSBI 'Research Centre for Medical Genetics' , Moscow , Russian Federation., Mozgovoy IV; c Department of Molecular and Cellular Genetics , The Russian National Research Medical University Named after N.I. Pirogov , Moscow , Russian Federation., Adilgereeva EP; a Laboratory of Mutagenesis , FSBI 'Research Centre for Medical Genetics' , Moscow , Russian Federation., Shukhov OA; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Petrova AN; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Bykova AV; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Abdullaev AO; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Turkina AG; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Kutsev SI; a Laboratory of Mutagenesis , FSBI 'Research Centre for Medical Genetics' , Moscow , Russian Federation.; c Department of Molecular and Cellular Genetics , The Russian National Research Medical University Named after N.I. Pirogov , Moscow , Russian Federation. |
